Clinical Trial Update: Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial [Phase 2]

View source ↗

Summary

Exploratory Phase II multicenter trial assessing efficacy and safety of plitidepsin in advanced unresectable/metastatic dedifferentiated liposarcoma; trial term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma

Drugs mentioned

• Plitidepsin (plitidepsin)

Snippet

Sponsor: Institut Bergonié | Conditions: Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma | Phase 2 | Status: TERMINATED | Results posted: 2019-11-12